Вы находитесь на странице: 1из 6


Pathophysiology of septic encephalopathy: A review

Marios C. Papadopoulos, MD, FRCS; D. Ceri Davies, PhD; Ray F. Moss; Derek Tighe, PhD; E. David Bennett, FRCP

Objectives: Encephalopathy is a common complication of sepsis. This review describes the different pathologic mechanisms that may be involved in its etiology. Data Sources: The studies described here were derived from the database PubMed (http:\\www.nlm.nih.gov) and from references identied in the bibliographies of pertinent articles and books. The citations are largely conned to English language articles between 1966 and 1998. Older publications were used if they were of historical signicance. Study Selection: All investigations in which any aspect of septic encephalopathy was reported were included. This selection encompasses clinical, animal, and in vitro cell culture work. Data Extraction: The literature cited was published in peerreviewed clinical or basic science journals or in books.

Data Synthesis: Contradictions between the results of published studies are discussed. Conclusions: The most immediate and serious complication of septic encephalopathy is impaired consciousness, for which the patient may require ventilation. The etiology of septic encephalopathy involves reduced cerebral blood ow and oxygen extraction by the brain, cerebral edema, and disruption of the bloodbrain barrier that may arise from the action of inammatory mediators on the cerebrovascular endothelium, abnormal neurotransmitter composition of the reticular activating system, impaired astrocyte function, and neuronal degeneration. Currently, there is no treatment. (Crit Care Med 2000; 28:3019 3024) KEY WORDS: astrocytes; blood-brain barrier; brain edema; cerebrovascular circulation; inammation; intensive care; leukocytes; neurons; sepsis; vascular endothelium

ncephalopathy is a deterioration of mental state or level of consciousness initiated by a disease process extrinsic to the brain. The word encephalopathy originates from the Greek (inside), (head), and os (suffering). Sepsis (Greek s) literally means putrefaction, but is now dened as clinical evidence of infection, with systemic sequelae such as increased respiratory rate, increased heart rate, abnormal body temperature, and inadequate organ perfusion (1). Recognition of the association between infection and impaired brain function dates back 2,500 yrs to Hippocrates, who described patients with fevers, abscesses or spreading redness, and swelling of the limbs that developed phrenitis (2). Subsequently, Galen (approximately 200 AD) pointed out that inammation often affected the mind sympathetically, causing delirium (3) and more recently Sir William Osler (1892) noted that sepsis impaired brain function

From the Departments of Anaesthetics and Intensive Care Medicine (Drs. Papadopoulos, Tighe, Bennett), Anatomy and Developmental Biology (Dr. Davies), and Electron Microscopy (Mr. Moss), St. Georges Hospital Medical School, London, UK. Copyright 2000 by Lippincott Williams & Wilkins

(4). The encephalopathy of sepsis can be classied as either early or septic encephalopathy, that presents before multiple organ failure occurs or late encephalopathy that is accompanied by multiple organ failure, hypotension, and other systemic phenomena. The concept of early or septic encephalopathy as an entity that cannot be explained by hepatic or renal dysfunction, hypotension, or hypoxia is relatively new. Septic encephalopathy was originally dened as altered brain function related to the presence of microorganisms or their toxins in the blood (5). However, this denition is inaccurate because neither microorganisms nor their products can be isolated from the blood of many septic patients (1, 6). Septic encephalopathy probably arises from the action of inammatory mediators on the brain or a cytotoxic response by brain cells to these mediators. Sepsis and its sequelae, sepsis syndrome, septic shock, and acute respiratory distress syndrome, are the leading causes of mortality in intensive care units, accounting for 10% to 50% of deaths (7, 8). Septic encephalopathy has been reported to occur in 8% to 70% of septic patients (6, 8, 9) and is the most common form of encephalopathy among patients in intensive care units (10). The

large variation in the reported incidence of septic encephalopathy probably results from the different denitions of sepsis and encephalopathy used. Septic encephalopathy is probably underdiagnosed because many critically ill patients receive treatments such as sedation, mechanical ventilation, or neuromuscular junction blockade that mask the signs of neural dysfunction. Septic patients may also have renal or liver failure, acute respiratory distress syndrome, electrolyte disturbances, acid-base alterations, hypo/ hyperglycemia, hypotension, hypoxemia, hypo/hyperthermia, or endocrine abnormalities (11). These associated conditions make it difcult for the effects of sepsis on the brain to be studied in isolation. Nevertheless, the onset of encephalopathy often precedes these abnormalities (12), suggesting that septic encephalopathy is not caused by them.

A diagnosis of septic encephalopathy requires evidence of extracranial infection and impaired mental state. Extracranial infection may be apparent from the history and examination, but blood cultures are positive in 50% of septic patients and a focus on infection may be

Crit Care Med 2000 Vol. 28, No. 8

difcult to nd (13). A group of 69 septic patients showed impaired attention, orientation, concentration and writing, and (in more severe cases) delirium and coma (9). In contrast to structural brain lesions, encephalopathy is characterized by symmetrical neurologic ndings. The asterixis, tremor, and multifocal myoclonus found in encephalopathy resulting from liver, kidney, or endocrine gland failures are infrequent in sepsis (9). Hypoxemia, hypotension, peripheral organ failure, and the presence of exogenous drugs should be excluded. Meningitis, encephalitis, brain abscess, and subdural empyema are important differentials to exclude using lumbar puncture, computed tomography, or magnetic resonance imaging. Electroencephalography is more sensitive than bedside testing in identifying septic encephalopathy (14) and may be valuable in intensive care units where clinical assessment is difcult. The severity of encephalopathy, which can be graded by the degree of electroencephalographic abnormality (14, 15) or in more severe cases by the Glasgow Coma Scale score (16), correlates with mortality.

The pathophysiology of septic encephalopathy is likely to be multifactorial. Early reports suggested that septic encephalopathy may be caused by disseminated cerebral microabscesses (17, 18), but a more recent postmortem study (10) failed to nd microabscesses in the brains of four patients with septic encephalopathy. Similar proportions of septic patients with Gram-negative bacteremia, Grampositive bacteremia, fungemia, or with no identied causative organism develop septic encephalopathy (6). These ndings, together with the fact that encephalopathy occurs in noninfectious conditions such as pancreatitis (19), suggest that infecting organisms and/or their toxins do not directly cause encephalopathy. The systemic inammation resulting from infection or other causes, appears more likely to be the cause of septic encephalopathy (20). Inammatory mediators released by leukocytes in sepsis have profound effects on endothelial cells and astrocytes; damage to these cells results in impaired neuronal function. Therefore, this review concentrates on four cell types that play a crucial role in the pathogenesis of septic encephalopathy: leuko3020

cytes, cerebral microvessel endothelial cells, astrocytes, and neurons. Leukocytes. The sequence of events leading to systemic inammation has been reviewed elsewhere (20). Although inammation is initially a local process, in severe infections, massive tissue injury, and in the presence of large amounts of necrotic tissue, a systemic release of inammatory mediators occurs (systemic inammatory response syndrome) that has adverse effects on the liver, lung, kidney, and heart (2124). These organs suffer panendothelial injury that causes reduced patency of microvessels (25). The lungs, liver, and spleen are underperfused (24) and accumulate activated leukocytes (22) that release lysosomal enzymes and oxygen free radicals. In contrast to organs of the reticuloendothelial system, the brain is resistant to leukocyte accumulation (26). Intracerebral injection of platelet activating factor, interleukin-8, interleukin-1, or tumor necrosis factor- fails to cause leukocyte exudation into the brain parenchyma in mice (27). There are a number of reasons for this (28, 29). First, the central nervous system is devoid of a lymphatic system that sequestrates potential antigens. Second, the central nervous system is protected from inammatory cell inltration by the blood-brain barrier. Although cerebrovascular endothelial cell pinocytosis increases in sepsis (30 32), allowing immunologically relevant molecules to pass through, the intercellular tight junctions remain morphologically intact (30 33) and thus, probably constitute a barrier to inammatory cells. Third, cells of the central nervous system express very low levels of the major histocompatibility complex antigens, which play a fundamental role in the induction and regulation of immune responses. Finally, the cerebrovascular endothelium expresses very low levels of leukocyte adhesion molecules such as VCAM-1 and ICAM-1 compared with the peripheral vascular endothelium (28, 29). Although leukocyte accumulation does not occur in the brain during sepsis, inammatory mediators cross the bloodbrain barrier and have adverse effects on the brain. Tumor necrosis factor- and interferon- increase the permeability of cultured bovine (30) and human (31) cerebral endothelial cells by promoting pinocytosis without apparently affecting the intercellular tight junctions. Intracerebral injection of interleukin-1 or interleukin-2 into experimental animals has

been reported to mimic the electroencephalographic changes and soporic effects of septic encephalopathy (34 36) and to cause fever by their effect on the hypothalamus (37). Subarachnoid injection of tumor necrosis factor- in rabbits reduces cerebral oxygen uptake and cerebral blood ow and increases intracranial pressure and cerebrospinal uid lactate (38). Tumor necrosis factor- enhances the production of endothelin and inhibits the formation of nitric oxide by cultured cerebral endothelial and smooth muscle cells (39). Activated leukocytes in the circulation generate oxygen free radicals that react with erythrocyte cell membranes and reduce the deformability of normal human erythrocytes treated with endotoxin (40, 41), erythrocytes in septic patients (42), erythrocytes in dogs infused with Escherichia Coli (43), and erythrocytes in rats after cecal ligation and puncture (44 46). Erythrocytes in cerebral microvessels appear enlarged and rounded in pigs with fecal peritonitis (33). These abnormally-shaped erythrocytes may be unable to squeeze through microvessels, thus exacerbating the cerebral hypoperfusion that occurs in sepsis (47, 48). Inotropes improve cardiac output that may be suppressed in the later stages of sepsis. 2 adrenergic agents are also antiinammatory (49 52), but 1-adrenergic agents are proinammatory (53, 54). In pigs with faecal peritonitis, dopexamine (a 2 adrenoceptor, vascular DA1 receptor, and prejunctional DA2 receptor agonist) protects against cerebral edema (55) and attenuates the leukostasis that occurs in the liver (56). Further studies are required to assess whether inotropes with 1 activity aggravate septic encephalopathy in humans, whereas inotropes with 2 activity offer protection against septic encephalopathy in humans. Cerebral Endothelial Cells. Blood is separated from the brain parenchyma by the blood-brain barrier, which depends on the integrity of cerebral microvessel endothelial cells. Normal cerebral microvessel endothelium, in contrast to that of most other tissues, has no fenestrations, possesses intercellular tight junctions, and contains few pinocytotic vesicles (57, 58). Septic encephalopathy appears to be associated with breakdown of the blood-brain barrier because patients with septic encephalopathy have high protein levels in the cerebrospinal uid (14) and colloidal iron oxide (32), 14 C-amino acids (59), and 125I-albumin
Crit Care Med 2000 Vol. 28, No. 8

(24) pass from the circulation into the brain parenchyma in septic rodents. Normally, low doses of circulating catecholamines have no effect on cerebral blood vessels because they are excluded from the central nervous system by the blood-brain barrier (60, 61). Higher concentrations of circulating catecholamines may result in dilation of cerebral blood vessels resulting from an increase in arterial blood pressure and thus, distension of the vascular walls. Disruption of the blood-brain barrier allows the high levels of endogenous catecholamines that occur in sepsis (61) and the various vasopressors administered in intensive care units to directly inuence cerebral vascular resistance (62). Agents with 1-adrenoceptor activity, such as norepinephrine, have been reported to cross the blood-brain barrier and cause cerebral vasoconstriction in sepsis (63). In contrast, during hemorrhagic shock, where blood-brain barrier permeability is unaffected, norepinephrine has no effect on the cerebral vasculature (64). Impaired blood-brain barrier function may also explain why cerebral oxygen consumption is 33% of normal in septic patients and remains constant when the cerebral blood ow is increased (47, 48). The cerebral perimicrovessel edema, seen in pigs after fecal peritonitis (33) and in rabbits with endotoxemia (32), is likely to limit the diffusion and hence utilization of oxygen, nutrients, and cellular waste across the microvessel wall. In dogs (65), pigs (63), and humans (47, 48), endotoxic shock has been shown to cause a reduction in cerebral blood ow that cannot be increased by improving the mean arterial pressure with vasopressors, suggesting that cerebral edema may increase intracranial pressure in sepsis, thus opposing the increase in cerebral blood ow after elevation of mean arterial pressure. This hypothesis is also supported by the fact that endotoxemia in pigs causes intracranial hypertension despite arterial hypotension (66). Systemic administration of E. Coli endotoxin to healthy volunteers did not affect cerebral blood ow or the rate of cerebral oxygen metabolism, despite replicating many of the systemic and hemodynamic features of sepsis (67). Although this model of sepsis (67) avoids many of the confounding variables present in critically ill patients, the lack of effect of E. Coli endotoxin on the cerebral circulation probably reects the low dose of endotoxin used. Another
Crit Care Med 2000 Vol. 28, No. 8

cause of impaired cerebral oxygen utilization during sepsis may be the inhibition of mitochondrial function. There is evidence from rat liver, smooth muscle, and pulmonary epithelium that endotoxemia and proinammatory cytokines cause mitochondrial dysfunction, probably by nitric oxide-mediated mechanisms (68). Alternatively, the reduced brain oxygen extraction in sepsis may be caused by, rather than be the cause of, the reduced brain activity in sepsis. In pigs with fecal peritonitis (33) and rabbits with endotoxemia (32), the interendothelial cell tight junctions appear to remain morphologically intact, although the permeability of the blood-brain barrier was increased. Therefore, the functional status of the tight junctions is unclear and requires investigation. Because the molecular structure of tight junctions has recently been elucidated (69), it would be interesting to use immunohistochemistry to investigate whether the glue-like tight junction protein occludin and its intracellular anchor ZO-1 are functionally disrupted in sepsis. Astrocytes. The perivascular endfeet of cortical astrocytes are disrupted in pigs with fecal peritonitis (33) and in rabbits injected with endotoxin (32). Astrocytes are important supportive and homeostatic cells in the central nervous system (70) and their injury may exacerbate neuronal damage by several mechanisms. First, in regions of high neuronal activity, there is a potassium ux from neurons to the extracellular space. The potassium is taken up by astrocytes and transferred to endothelial cells. It is then secreted into the vascular lumen to dilate local blood vessels (70, 71). Astrocyte damage may thus impair the regulation of local blood ow. Second, astrocytes transport energy substrates from microvessels to neurons in proportion to the level of synaptic activity (72). Injury to astrocyte endfeet may impair this coupling process and therefore reduce synaptic activity. Third, astrocytes are important in inducing blood-brain barrier properties in the cerebral endothelium (73) and their damage may exacerbate the increased bloodbrain barrier permeability in sepsis. Astrocytes possess receptors for inammatory mediators (74). In human astrocyte cultures, recombinant human -interferon and interleukin-1 induce the formation of reactive oxygen intermediates (75) that are toxic (76). Free radical scavengers inhibit the electrophysiological changes seen after addition of

sepsis and septic patients with encephalopathy have a higher mortality than those without encephalopathy. These ndings suggest that encephalopathy may be a cause of death in septic patients.

ncephalopathy is often the rst manifestation of

various interferons to hippocampal slices (77). The results of experiments using rodent cell cultures suggest that astrocytes inuence the vulnerability of neurons to hypoxic (78), excitotoxic (79), and free radical-mediated (80) injuries. Therefore, the role of astrocytes in modulating neuronal damage in sepsis merits further study. Neurons. Septic encephalopathy is associated with disturbances of the reticular activating system that controls consciousness and attention. Cecal ligation and puncture in rats has been shown to increase glucose utilization by the raphe nuclei (81) and to increase the turnover of serotonin throughout the brain (82). In the same animal model of sepsis, glucose utilization by the locus ceruleus (81) and the norepinephrine content of the whole brain were found to be reduced (83). Enhanced serotoninergic and reduced noradrenergic neurotransmission have also been reported in hepatic (84) and uremic (85) encephalopathy and may, therefore, be universal features of the encephalopathies (86, 87). However, it is unclear whether these changes in neurotransmission are causes of encephalopathy or epiphenomena. Altered levels of tyrosine, tryptophan, and phenylalanine might explain the changes in neurotransmission found in sepsis, although the data should be interpreted with caution because such alterations may be secondary to the liver and renal failure that occurs in sepsis. The

plasma and brain concentrations of these aromatic amino acids are increased in septic patients (88, 89) and in rats after cecal ligation and puncture (59), because they are released into the circulation from muscle breakdown (90, 91). In humans, the severity of septic encephalopathy can be predicted from the plasma concentrations of these amino acids (89, 92), suggesting that they contribute to its pathophysiology. Increased brain levels of the serotonin precursor tryptophan may be responsible for the potentiation of the reticular activating system serotonergic pathways. Intracarotid infusion of tryptophan has been shown to induce drowsiness and sleepiness in dogs (93). The high concentrations of tyrosine and phenylalanine in septic brains have been reported to cause increased levels of their breakdown products, -phenylethylamine and octopamine (91, 92, 94). These false neurotransmitters may be responsible for the inhibition of the central noradrenergic pathways (91, 94). Furthermore, administration of phenylalanine to dogs (93) and mice (95) has been shown to induce hypoactivity, ingestion of phenylalanine by a human volunteer caused lethargy (96), and congenital disorders of phenylalanine metabolism lead to encephalopathy (97). Branched-chain amino acids compete with aromatic amino acids for transport across the blood-brain barrier (88 93). They are used as energy sources in sepsis, causing a fall in their plasma and brain levels (88 93). Administration of branched chain amino acid-rich solutions to a group of septic patients has been reported to normalize plasma amino acid levels and to reverse encephalopathy (88, 91). However, these results must be treated with caution because the patients were also subjected to antibiotic treatment and abscess drainage. Dark, shrunken, apparently degenerating neurons are present in the frontal cortices of hemodynamically controlled pigs after only 8 hrs of fecal peritonitis (33). This is an important nding because septic encephalopathy was previously thought to be reversible (12, 86). Neuronal injury was not reported in rabbits injected with endotoxin, (32) suggesting possible differences between species or in the severity of sepsis. It is not known whether neuronal injury occurs in septic humans. However, because the duration of sepsis is typically considerably 8 hrs

in critically ill patients, their neuronal damage might be even more severe than that observed in the pig model. Although septic encephalopathy occurs before cerebral hypoperfusion, cerebral hypoxia/ischemia could potentially contribute to neuronal death in sepsis. In septic patients, cerebral blood ow is reduced to 62% of normal (47, 48). This decrease does not appear to be enough to threaten neuronal viability or to cause electroencephalographic changes (98, 99) because cerebral blood ow needs to fall to 45% before the electroencephalogram is affected and to 33% for anoxic depolarization of neurons to occur (98, 99). Even if cerebral blood ow in sepsis is sufcient for the baseline energy requirements of neurons, it may become functionally limiting during high synaptic activity. Impaired cerebral blood ow may therefore inhibit the processing of complex information and thus contribute to the symptoms of septic encephalopathy, unless it is the reduced neuronal activity that occurs in sepsis, which causes the decrease in cerebral blood ow. In a study of eight septic patients (47), the cerebrovascular response to changes in the arterial partial pressure of carbon dioxide was found to remain intact, despite the depression of cerebral blood ow. However, it is not clear whether hyperventilation in sepsis would further compromise cerebral blood ow and thus exacerbate the encephalopathy. Augmentation of -amino butyric acid-mediated neurotransmission by endogenous benzodiazepine ligands may contribute to the impaired motor function and decreased consciousness in hepatic encephalopathy (100); the role of the -amino butyric acid system in septic encephalopathy awaits identication. Glutamate is considered to be the neurotransmitter in 40% of the synapses in the brain (101). Glutamate, released by damaged neurons and by reverse transport of the astrocyte glutamate carrier (102, 103), causes neuronal injury (excitotoxicity) in many disorders, including hepatic encephalopathy (102). Its role in septic encephalopathy has not been evaluated. There are no published studies of the genetic response of neurons to sepsis, despite the sizeable literature that shows the importance of gene products such as hsp-70, bcl-2, p53, HO-1, and the caspases in other forms of brain damage such as ischemia (103).

Encephalopathy is often the rst manifestation of sepsis (12, 86) and septic patients with encephalopathy have a higher mortality than those without encephalopathy (6, 9, 10, 15). These ndings suggest that encephalopathy may be a cause of death in septic patients. Although often unrecognized, it would appear that brain injury occurs in sepsis at least as frequently as damage to other organs. Free radicals produced by leukocytes damage erythrocytes and thus limit oxygen delivery to the brain. Inammatory mediators released by leukocytes impair mitochondrial function and oxygen extraction by the brain. These mediators also open the blood-brain barrier, resulting in perimicrovessel edema and disruption of astrocyte endfeet. Aromatic amino acids enter the brain parenchyma and disturb the neurotransmitter content of the brain. Ultimately, these changes appear to cause extensive neuronal injury and thus, the possibility exists that patients who recover from sepsis may have long-term neuropsychiatric/ neurologic decits.

1. Bone RC: Sepsis, the sepsis syndrome multi-organ failure: A plea for comparable denitions. Ann Intern Med 1991; 114: 332333 2. Chadwick J, Mann WN (Eds): The Medical Works of Hippocrates. Oxford, Blackwell, 1950, pp 50, 223 3. Mendez MF: Delirium. In: Neurology in Clinical Practice. Volume 1. Second Edition. Bradley WG, Daroff RB, Fenichel GM, et al (Eds). Boston, Butterworth-Heinemann, 1996, pp 29 38 4. Osler W: The Principles and Practice of Medicine. New York, Appleton, 1892, pp 114 118 5. Bolton CF, Young GB: Neurological complications in critically ill patients. In: Neurology and General Medicine. Aminoff MJ (Ed). New York, Churchill Livingstone, 1989, pp 713729 6. Sprung CL, Peduzzi PN, Shatney CH, et al: Impact of encephalopathy on mortality in the sepsis syndrome. Crit Care Med 1990; 18:801 806 7. Tran DD, Groeneveld AAJB, van der Meulen J, et al: Age, chronic disease, sepsis, organ system failure, and mortality in a medical intensive care unit. Crit Care Med 1990; 18:474 479 8. Pine RW, Wertz MJ, Lennard ES, et al: Determinants of organ malfunction or death in patients with intra-abdominal sepsis. Arch Surg 1983; 118:242249

Crit Care Med 2000 Vol. 28, No. 8

9. Young GB, Bolton CF, Austin TW, et al: The encephalopathy associated with septic illness. Clin Invest Med 1990; 13:297304 10. Bleck TP, Smith MC, Pierre-Louis SJ-C, et al: Neurologic complications of critical medical illnesses. Crit Care Med 1993; 21: 98 103 11. Carrico CJ, Meakins J, Marshall JC, et al: Multiple organ failure syndrome. Arch Surg 1986; 121:196 208 12. Bolton CF, Young GB, Zochodne DW: The neurological complications of sepsis. Ann Neurol 1993; 33:94 100 13. Meakins JL, Wicklund B, Forse RA, et al: The surgical intensive care unit: Current concepts in infection. Surg Clin North Am 1980; 60:117132 14. Young CB, Bolton CF, Archibald YM: The electroencephalogram in sepsis-associated encephalopathy. J Clin Neurophysiol 1992; 9:145152 15. Straver JS, Keunen RWM, Stam CJ, et al: Nonlinear analysis of EEG in septic encephalopathy. Neurol Res 1998; 20:100 106 16. Eidelman LA, Putterman D, Putterman C, et al: The spectrum of septic encephalopathy: Denitions, etiologies, and mortalities. JAMA 1996; 275:470 473 17. Jackson AC, Gilber JJ, Young GB, et al: The encephalopathy of sepsis. Can J Neurol Sci 1985; 12:303307 18. Pendlebury WW, Perl DP, Munoz DG: Multiple microabscesses in the central nervous system. J Neuropathol Exp Neurol 1989; 48:290 300 19. Estrada RV, Moreno J, Martinez E, et al: Pancreatic encephalopathy. Acta Neurol Scand 1979; 59:135139 20. Goris RJA: Mediators of multiple organ failure. Intensive Care Med 1990; 16: S192S196 21. Lang CH, Bagby GJ, Ferguson JL, et al: Cardiac output and redistribution of organ blood ow in hypermetabolic sepsis. Am J Physiol 1984; 246:R331R337 22. Tighe D, Moss R, Boghossian S, et al: Multiorgan damage resulting from experimental faecal peritonitis. Clin Sci 1989; 76: 269 276 23. Tighe D, Moss R, Hynd J, et al: Pretreatment with pentoxifylline improves the hemodynamic and histological changes and decreases neutrophil adhesiveness in a pig fecal peritonitis model. Crit Care Med 1990; 18:184 189 24. Deng X, Wang X, Anderson R: Endothelial barrier resistance in multiple organs after septic and nonseptic challenges in the rat. J Appl Physiol 1995; 78:20522061 25. Bradley JR, Wilks D, Rubenstein D: The vascular endothelium in septic shock. J Infect 1994; 28:110 26. Perry VH, Andersson PB, Gordon S: Macrophages and inammation in the central nervous system. Trends Neurosci 1993; 16: 268 273 27. Andersson PB, Perry VH, Gordon S: Intracerebral injection of proinammatory cyto-










37. 38.





kines or leukocyte chemotaxins induces minimal myelomonocytic cell recruitment to the parenchyma of the central nervous system. J Exp Med 1992; 176:255259 dos Santos WL, Rahman J, Klein N, et al: Control of lymphocyte adhesion to brain and aortic endothelium: ICAM-1, VCAM-1 and negative charge. J Neuroimmunol 1996; 66:125134 Benveniste EN: Cytokine expression in the central nervous system. In: Immunology of the central nervous system. Keane RW and Hickey WF (Eds). New York, Oxford University Press, 1997; pp 419 459 Anda T, Yamashita H, Tsutsumi K, et al: Effect of tumor necrosis factor-alpha on the permeability of bovine brain microvessel endothelial cell monolayers. Neurol Res 1997; 19:369 376 Huynh HK, Dorovini-Zis K: Effects of interferon-gamma on primary cultures of human brain microvessel endothelial cells. Am J Pathol 1993; 142:12651278 Clawson CC, Hartmann JF, Vernier RL: Electron microscopy of the effect of gramnegative endotoxin on the blood-brain barrier. J Comp Neurol 1966; 127:183198 Papadopoulos MC, Moss RF, Lamb FJ, et al: Faecal peritonitis causes oedema and neuronal injury in pig cerebral cortex. Clin Sci 1999; 96:461 466 Krueger J, Walter J, Dinarello CA, et al: Sleep-promoting effects of endogenous pyrogen (interleukin-1). Am J Physiol 1984; 246:R994 999 Reyez-Vazquez C, Prieto-Gomez B, Georgiades JA, et al: Alpha and gamma interferons effects on cortical and hippocampal neurons: Microiontophoretic application and single-cell recording. Int J Neurosci 1984; 25:113121 Nistico G, De Sarro G: Is interleukin-2 a neuromodulator in the brain? Trends Neurosci 1991; 14:146 150 Dinarello CA: Interleukin-1. Rev Infect Dis 1984; 6:5295 Tureen J: Effect of recombinant human tumor necrosis factor-alpha on cerebral oxygen uptake, cerebrospinal uid lactate, and cerebral blood ow in the rabbit: Role of nitric oxide. J Clin Invest 1995; 95: 1086 1091 Estrada C, Gomez C, Martin C: Effects of TNF-alpha on the production of vasoactive substances by cerebral endothelial and smooth muscle cells in culture. J Cereb Blood Flow Metab 1995; 15:920 928 Machiedo GW, Powell RJ, Rush BF Jr, et al: The incidence of red blood cell deformability in sepsis and the association with oxygen free radical damage and multiple-system organ failure. Arch Surg 1989; 124: 1386 1389 Todd JC, Poulos ND, Davidson LW, et al: Role of the leukocyte in endotoxin-mediated alterations of the red cell membrane. Am Surg 1993; 59:9 12 Ismail NH, Cohn EJ Jr, Mollitt DL: Nitric
















oxide synthase inhibition negates septicinduced alterations in cytoplasmic calcium homeostasis and membrane dynamics. Am Surg 1997; 63:20 23 Puranapanda V, Hinslaw LB, ORear EA, et al: Erythrocyte deformability in canine septic shock and the efcacy of pentoxifylline and a leukotriene antagonist. Proc Soc Exp Biol Med 1987; 185:206 210 Powell RJ, Machiedo GW, Rush BF Jr, et al: Oxygen free radicals: Effects on red cell deformability in sepsis. Crit Care Med 1991; 19:732735 Langenfeld JE, Machiedo GW, Lyons M, et al: Correlation between red blood cell deformability and changes in hemodynamic function. Surgery 1994; 116:859 867 Baskurt OK, Gelmont D, Meiselman HJ: Red blood cell deformability in sepsis. Am J Respir Crit Care Med 1998; 157:421 427 Bowton DL, Bertels NH, Prough DS, et al: Cerebral blood ow is reduced in patients with sepsis syndrome. Crit Care Med 1989; 17:399 403 Maekawa T, Fujii Y, Sadamitsu D, et al: Cerebral circulation and metabolism in patients with septic encephalopathy. Am J Emerg Med 1991; 9:139 143 Henney CS, Bourne HR, Lichtenstein LM: The role of 3,5 adenosine monophosphate in the specic cytolytic activity of lymphocytes. J Immunol 1972; 6:1526 1534 Bourne HR, Lichtenstein LM, Melmon KL, et al: Modulation of inammation and immunity by cyclic AMP. Science 1974; 184: 19 28 Melmon KL, Bourne HR, Weinstein Y, et al: Hemolytic plaque formation by leukocytes in vitro. J Clin Invest 1974; 53:1321 Kammer GM: The adenylate cyclase-cAMPprotein kinase A pathway and regulation of the immune response. Immunol Today 1988; 9:222229 Tighe D, Moss R, Bennett ED: Cell surface adrenergic receptor stimulation modies the endothelial response to SIRS. New Horiz 1996; 4:426 442 Burns AM, Keogan M, Donaldson M, et al: Effects of inotropes on human leukocyte numbers, neutrophil function and lymphocyte subtypes. Br J Anaesth 1997; 78: 530 535 Davies DC, Moss R, Tighe D, et al: Dopexamine hydrochloride inhibits cerebral oedema in porcine sepsis. In: 8th European Congress of Intensive Care Medicine. Roussos C (Ed). Bologna, Monduzzi Editore, 1995, pp 417 420 Tighe D, Moss R, Haywood G, et al: Dopexamine hydrochloride maintains portal blood ow and attenuates hepatic ultrastructural changes in a porcine peritonitis model of multiple system organ failure. Circ Shock 1993; 39:199 206 Peters A, Palay SL, Webster H deF: Blood vessels. In: The Fine Structure of the Nervous System. Neurons and Their Support-

Crit Care Med 2000 Vol. 28, No. 8












68. 69.






ing Cells. Third Edition. New York, Oxford University Press, 1991, pp 344 355 Joo F, Klatzo I: Role of cerebral endothelium in brain oedema. Neurol Res 1989; 11:6775 Jeppsson B, Freund HR, Gimmon Z, et al: Blood-brain barrier derangement in sepsis: Cause of septic encephalopathy? Am J Surg 1981; 141:136 141 Oldendoff WH: Brain uptake of radiolabeled amino acids, amines, and hexoses after arterial injection. Am J Physiol 1971; 221: 1629 1639 MacKenzie ET, McCulloch J, OKeane M, et al: Cerebral circulation and norepinephrine: Relevance of the blood-brain barrier. Am J Physiol 1976; 231:483 488 McCalden TA, Eidelman BH, Mendelow AD: Barrier and uptake mechanisms in the cerebrovascular response to noradrenaline. Am J Physiol 1977; 233:H458 H465 Breslow MJ, Miller CF, Parker SD, et al: Effect of vasopressors on organ blood ow during endotoxin shock in pigs. Am J Physiol 1987; 252:H291H300 Corday E, Williams JH Jr: Effect of shock and of vasopressor drugs on the regional circulation of the brain, heart, kidney, and liver. Am J Med 1960; 29:228 241 Ekstro m-Jodal B, Ha ggendal E, Larsson LE: Cerebral blood ow and oxygen uptake in endotoxic shock. An experimental study in dogs. Acta Anaesth Scand 1982; 26:163170 Hariri RJ, Ghajar JB, Bahramian K, et al: Alterations in intracranial pressure and cerebral blood volume in endotoxemia. Surg Gynecol Obst 1993; 176:155166 Pollard V, Prough DS, Deyo DJ, et al: Cerebral blood ow during experimental endotoxemia in volunteers. Crit Care Med 1997; 25:1700 1706 Fink M: Cytopathic hypoxia in sepsis. Acta Anaesth Scand 1997; 110:8795 Denker BM, Nigam SK: Molecular structure and assembly of the tight junction. Am J Physiol 1998; 43:F1F9 Landis DMD: Brain as a tissue: The interacting cell populations of the central nervous system. In: Cytokines and the CNS. Ransohoff RM, Benveniste EN (Eds). Boca Raton, CRC Press, 1996; pp 63 83 Paulson OB, Newman EA: Does the release of potassium ions from astrocyte endfeet regulate cerebral blood ow? Science 1987; 237 896 898 Tsacopoulos M, Magistretti PJ: Metabolic coupling between glia and neurons. J Neurosci 1996; 16:877 885 Janzer RC, Raff MC: Astrocytes induce blood-brain barrier properties in endothelial cells. Nature 1987; 325:253257 St. Pierre BA, Merrill JE, Dopp JM: Effects












86. 87.



of cytokines on CNS cells: Glia. In: Cytokines and the CNS. Ransohoff RM, Benveniste EN (Eds). Boca Raton, CRC Press, 1996; pp 151168 Lee SC, Dickson DW, Liu W, et al: Induction of nitric oxide synthase activity in human astrocytes by interleukin-1 and interferon-. J Neuroimmunol 1993; 46:19 24 Chao CC, Hu S, Molitor TW, et al: Activated microglia mediate neuronal cell injury via a nitric oxide mechanism. J Immunol 1992; 149:2736 2741 Muller M, Fontana A, Zbinden G, et al: Effects of interferons and hydrogen peroxide on CA3 pyramidal cells in rat hippocampal slice cultures. Brain Res 1993; 619:157162 Choi DW, Maulucci-Gedde M, Kriegstein AR: Glutamate neurotoxicity in cortical cell culture. J Neurosci 1987; 7:357368 Dugan LL, Bruno VMG, Amagasu SM, et al: Glia modulate the response of murine cortical neurons to excitotoxicity. Glia exacerbate AMPA neurotoxicity. J Neurosci 1995; 15:4545 4555 Desagher S, Glowinski J, Premont J: Astrocytes protect neurons from hydrogen peroxide toxicity. J Neurosci 1996; 16: 25532562 Soejima Y, Fujii Y, Ishikawa T, et al: Local cerebral glucose utilization in septic rats. Crit Care Med 1990; 18:423 427 Freund HR, Muggia-Sullam M, LaFrance R, et al: Regional brain amino acid and neurotransmitter derangements during abdominal sepsis and septic encephalopathy in the rat. Arch Surg 1986; 121:209 216 Freund HR, Muggia-Sullam M, Peiser J, et al: Brain neurotransmitter prole is deranged during sepsis and septic encephalopathy in the rat. J Surg Res 1985; 38:267271 Herlin PM, James JH, Nachbauer CA, et al: Effect of total hepatectomy and administration of branched chain amino acids on regional norepinephrine, dopamine, and amino acids in rat brain. Ann Surg 1983; 198:172177 Jeppsson B, Freund HR, Gimmon Z, et al: Blood-brain barrier derangement in uremic encephalopathy. Surgery 1982; 92:30 35 Chen R, Young GB: Metabolic encephalopathies. Balliere Clin Neur 1996; 5:577598 Lockwood AH: Toxic and metabolic encephalopathies. In: Neurology in Clinical Practice. Volume 2. Second Edition. Bradley WG, Daroff RB, Fenichel GM, et al (Eds). Boston, Butterworth-Heinemann 1996, pp 13551372 Freund HR, Ryan JA, Fischer JE: Amino acid derangements in patients with sepsis: Treatment with branched chain amino acid infusions. Ann Surg 1978; 118:423 430 Sprung CL, Cerra FB, Freund HR, et al:















Amino acid alterations and encephalopathy in the sepsis syndrome. Crit Care Med 1991; 19:753757 Rosenblatt S, Clowes GH Jr, George BC, et al: Exchange of amino acids by muscle and liver in sepsis. Arch Surg 1983; 118: 167175 Hasselgren PO, Fischer JE: Septic encephalopathy: Etiology and management. Intensive Care Med 1985; 12:1316 Freund H, Atamian S, Holroyd J, et al: Plasma amino acids as predictors of the severity and outcome of sepsis. Ann Surg 1979; 190:571576 Ross-Fanelli F, Cangiano C, Cascino A, et al: Branched chain amino acids in the treatment of severe hepatic encephalopathy. In: Hepatic Encephalopathy in Chronic Liver Failure. Capocaccia L, Fischer JE, RossFanelli F (Eds). New York, Plenum Press, 1984, p 335 Fischer JE, Horst WD, Kopin IJ: Betahydroxylated sympathomimetic amines as false neurotransmitters. Br J Pharmacol 1965; 24:477 480 Giardina WJ, Sabelli HC: Evidence for the biological activity of the deaminated metabolites of the adrenergic amines. Biol Psych 1974; 9:1123 Sherwin CP, Kennard KS: Toxicity of phenylacetic acid. J Biol Chem 1919; 40: 259 264 Evans OB, Parker C, Haas R, et al: Inborn errors of metabolism of the nervous system: Disorders of phenylalanine metabolism. In: Neurology in Clinical Practice. Volume 2. Second Edition. Bradley WG, Daroff RB, Fenichel GM, et al (Eds). Boston, Butterworth-Heinemann, 1996, pp 14951498 Astrup J, Siesjo BK, Symon L: Thresholds in cerebral ischemia. The ischemic penumbra. Stroke 1981; 12:723725 Hossmann KA: Viability thresholds and the penumbra of focal ischemia. Ann Neurol 1994; 36:557565 Jones EA, Weissenborn K: Neurology and the liver. J Neurol Neurosurg Psychiatry 1997; 63:279 293 Coyle JT, Puttfarcken P: Oxidative stress, glutamate and neurodegenerative disorders. Science 1993; 262:689 695 Butterworth RF: Hepatic encephalopathy and brain edema in acute hepatic failure: Does glutamate play a role? Hepatology 1997; 25:10321033 Giffard RG, Papadopoulos MC: Mechanisms of ischemic cell injury. In: Fetal and Neonatal Brain Injury: Mechanisms, Management and the Risks of Practice. Second Edition. Stevenson DK, Sunshine P, (Eds). Oxford, Oxford University Press, 1997, pp 24 38


Crit Care Med 2000 Vol. 28, No. 8